posted on 2024-02-12, 06:03authored byPei Zhu, Tianjie You, Ying Wang, Mingxue Ma, Sheng Ye, Si Liu
The
field of clinical surgery frequently encounters challenges
related to atypical wound tissue healing, resulting in the development
of persistent chronic wounds or aesthetically displeasing scar tissue.
The use of wound dressings crafted from mussel adhesive proteins and
hyaluronic acid has demonstrated the potential in mitigating these
undesirable outcomes. However, the synergistic effects of these two
biomaterials remain underexplored. In this study, we have engineered
a versatile, degradable, and biocompatible dressing that comprises
recombinant 3,4-dihydroxyphenylalanine (DOPA)-modified mussel adhesive
proteins and maleimide-functionalized hyaluronic acid. We have successfully
fabricated this biocompatible dressing and conducted comprehensive
experimental assessments to confirm its hemostatic, antibacterial,
and biocompatible characteristics. Importantly, this dressing exclusively
incorporates biologically derived materials characterized by low toxicity
and minimal immunogenicity, thus holding immense promise for clinical
applications in the field of wound healing.